Fig. 2From: Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancerKaplan Meier estimates for overall survival in patients with R0 resected T4 UICC II colorectal cancer, depending on tumor grading. Patients with G2 (a, p = 0.009) and G3 (b, p = 0.014) tumors benefited significantly from adjuvant chemotherapyBack to article page